Post-IPO Equity - Outlook Therapeutics - Dec 23, 2022 Funding Round Profile - Cointime

Bitcoin $91,759.79 -2.61%
Ethereum $3,325.50 -3.84%
BNB $614.11 -3.76%
Optimism $2.21 -6.08%
Arbitrum $0.87 -7.05%
Solana $230.14 -2.88%
Polygon $0.53 -5.27%
Cosmos $7.94 -0.57%
Avalanche $42.81 +2.18%

Bitcoin $91,759.79 -2.61%
Ethereum $3,325.50 -3.84%
BNB $614.11 -3.76%
Optimism $2.21 -6.08%
Arbitrum $0.87 -7.05%
Solana $230.14 -2.88%
Polygon $0.53 -5.27%
Cosmos $7.94 -0.57%
Avalanche $42.81 +2.18%

Outlook Therapeutics

company

Funding Round

Post-IPO Equity

Money Raised

$ 25M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
GMS Holdings	-	Yes	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Dec 22, 2022	Post-IPO Debt	$ 6.80M		Detail
May 26, 2020	Post-IPO Equity	$ 27.20M	Syntone Ventures	Detail
Jul 27, 2015	Series Unknown	$ 31M	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Nov 5, 2018	Post-IPO Equity	$ 20M	Biolexis	Detail
Nov 29, 2021	Post-IPO Equity	$ 57.50M		Detail
Jan 29, 2021	Post-IPO Equity	$ 35M		Detail
Feb 16, 2021	Post-IPO Equity	$ 42.60M		Detail
Sep 29, 2015	Series Unknown	0	Cormorant Global Healthcare Master Fund,Longwood Capital Partners,etc.	Detail
Feb 24, 2020	Post-IPO Equity	$ 10.20M		Detail
May 14, 2018	Post-IPO Equity	$ 15M	GMS Tenshi Holdings	Detail
May 13, 2016	IPO	$ 35M		Detail